Video
The fifth edition of IBS Days, a congress entirely dedicated to Irritable Bowel Syndrome, will take place in Bologna, Italy, from June 15 to 17, 2026.
Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.
Giovanni Marasco, University of Bologna, discusses the growing evidence that links gut microbiota dysbiosis to the pathophysiology, clinical prognosis, disease progression, and treatment response of patients with IBD.
Ivana Gandolfi, International Diary Federation, describes the emerging concept of the food matrix.
Francisco Guarner Aguilar reviewed some of the most significant probiotic-related papers published in recent years, spanning basic research, clinical trials, and population-based studies.
Emma Allen-Vercoe, from University of Guelph (Canada) focuses on the gut microbiome of the Yanomami, whose exceptionally strong cardiometabolic health has attracted growing scientific interest.
Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.
Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.
Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.
Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.
